(Q38006281)

English

Pneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults

scientific article published on 26 April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Pneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

0 references

0 references

author name string

John D Grabenstein

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Susan B Manoff

2

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

language of work or name

0 references

publication date

26 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

4435-4444

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Protective immunity following vaccination: how is it defined?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Booster vaccinations: can immunologic memory outpace disease pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Evaluation of the persistence of vaccine-induced protection with human vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Serum therapy revisited: animal models of infection and development of passive antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Revaccination with a 23‐Valent Pneumococcal Polysaccharide Vaccine Induces Elevated and Persistent Functional Antibody Responses in Adults Aged ⩾65 Years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55–74 years living in Alaska: No evidence of hyporesponsiveness☆☆☆

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Pneumococcal Vaccination and Revaccination of Older Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Immunogenetic analysis of the immune response to pneumococcal polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

T cell-independent B cell memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Pneumococcal vaccines in adults: assessing the evolving evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Dependence of correlations between antibody titres and opsonophagocytosis on pneumococcal serotype and patient morbidity in pre- and post-pneumococcal vaccination states

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Persistence of Pneumococcal antibodies in human subjects following vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Long-term persistence of antibody following immunization with pneumococcal polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Reactivity and antibody responses of volunteers given two or three doses of pneumococcal vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Pneumococcal antibodies (IgG, IgM) in patients with chronic obstructive lung disease 3 years after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Pneumococcal antibody levels one decade after immunization of healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Antibody persistence in splenectomized adults after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Antibody to Capsular Polysaccharides of Streptococcus pneumoniae: Prevalence, Persistence, and Response to Revaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Immunogenicity of pneumococcal revaccination in patients with chronic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Immunogenicity of pneumococcal vaccine in renal transplant recipients--three year follow-up of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Safety of revaccination with pneumococcal polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Recurrence of pneumonia in relation to the antibody response after pneumococcal vaccination in middle-aged and elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Persistence of antibodies to pneumococcal capsular polysaccharide vaccine in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Pneumococcal polysaccharide revaccination: immunoglobulin g seroconversion, persistence, and safety in frail, chronically ill older subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Severe local reactions to pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Assessing pneumococcal revaccination safety among New York State Medicare beneficiaries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Safety and acceptability of pneumococcal vaccinations administered in nontraditional settings

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Safety of pneumococcal revaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Efficacy and safety of pneumococcal revaccination after splenectomy for trauma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Associations of prevaccination antibody levels with adverse reactions to pneumococcal and influenza vaccines administered simultaneously in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Evaluating adverse events after vaccination in the Medicare population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Reactions after 3 or more doses of pneumococcal polysaccharide vaccine in adults in Alaska

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Pneumococcal vaccination and revaccination in the elderly population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Passive immunity in prevention and treatment of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

A Randomized Study Comparing Combined Pneumococcal Conjugate and Polysaccharide Vaccination Schedules in Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

ANTIPNEUMOCOCCIC IMMUNITY REACTIONS IN INDIVIDUALS OF DIFFERENT AGES.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Vaccines for preventing pneumococcal infection in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Antibody response of pneumococcal vaccine: need for booster dosing?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumococcal Vaccine: Dose, Revaccination, and Coadministration with Influenza Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination and Revaccination with Polyvalent Pneumococcal Polysaccharide Vaccines in Adults and Infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.052

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.04.052

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38006281&oldid=1736974157"